Carboranylanilinoquinazoline EGFR-Inhibitors: Toward ‘Lead-to-Candidate’ Stage in the Drug-Development Pipeline

References

• Alphandéry E . Glioblastoma treatments: an account of recent industrial developments. Front. Pharmacol.9, 879 (2018).
   PubMed Web of Science ®Google Scholar
• Messaoudi K , ClavreulA, LagarceF. Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide. Drug Discov. Today20, 899–905 (2015).
   PubMed Web of Science ®Google Scholar
• Crespo I , VitalAL, Gonzalez-TablasMet al. Molecular and genomic alterations in glioblastoma multiforme. Am. J. Pathol.185, 1820–1833 (2015).
   PubMed Web of Science ®Google Scholar
• Tuncel G , KalkanR. Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiforme. Med. Oncol.35, 122 (2018).
   PubMed Web of Science ®Google Scholar
• Prados MD , ChangSM, ButowskiNet al. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J. Clin. Oncol.27, 579–84 (2009).
   PubMed Web of Science ®Google Scholar
• Conger AD , GilesNH. The cytogenetic effect of slow neutrons. Genetics35, 397–419 (1950).
   PubMed Web of Science ®Google Scholar
• Calabrese G , DaouA, BarbuE, TsibouklisJ. Towards carborane-functionalised structures for the treatment of brain cancer. Drug Discov. Today23, 63–75 (2018).
   PubMed Web of Science ®Google Scholar
• Hiratsuka J , KamitaniN, TanakaRet al. Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget's disease with curative responses. Cancer Commun.38, 38 (2018).
   Web of Science ®Google Scholar
• Trivillin VA , PozziECC, ColomboLLet al. Abscopal effect of boron neutron capture therapy (BNCT): proof of principle in an experimental model of colon cancer. Radiat. Environ. Biophys.56, 365–375 (2017).
   PubMed Web of Science ®Google Scholar
• Hey-Hawkins E , ViñasC. Boron-Based Compounds: Potential and Emerging Applications in Medicine. John Wiley & Sons Incorporated, NJ, USA (2018).
   Google Scholar
• Couto M , MastandreaI, CabreraMet al. Small-molecule kinase-inhibitors-loaded boron cluster as hybrid agents for glioma-cell-targeting therapy. Chem. Eur. J.23, 9233–9238 (2017).
   PubMed Web of Science ®Google Scholar
• Nakamura H , HorikoshiR, UsuiT, BanHS. Selective inhibition of EGFR and VEGFR2 tyrosine kinases controlled by a boronic acid substituent on 4-anilinoquinazolines. MedChemComm1, 282–286 (2010).
   Web of Science ®Google Scholar
• Couto M , GarcíaMF, AlamónCet al. Discovery of potent EGFR inhibitors through the incorporation of a 3D-aromatic-boron-rich-cluster into the 4-anilinoquinazoline scaffold: potential drugs for glioma treatment. Chem. Eur. J.24, 3122–3126 (2018).
   PubMed Web of Science ®Google Scholar
• Mamot C , DrummondDC, GreiserUet al. Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. Cancer Res.63, 3154–3161 (2003).
   PubMed Web of Science ®Google Scholar
• Cheng CC , LiaoPN, HoASet al. STAT3 exacerbates survival of cancer stem-like tumor spheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening. J. Biomed. Sci.25, 60 (2018).
   PubMed Web of Science ®Google Scholar
• Cheng F , LiW, ZhouYet al. admetSAR: a comprehensive source and free tool for evaluating chemical ADMET properties. J. Chem. Inf. Model.52, 3099–3105 (2012).
   PubMed Web of Science ®Google Scholar
• Marchese Robinson RL , GlenRC, MitchellJBO. Development and comparison of hERG blocker classifiers: assessment on different datasets yields markedly different results. Mol. Inf.30, 443–458 (2011).
   PubMed Web of Science ®Google Scholar
• Wang S , LiY, WangJet al. ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage. Mol. Pharm.9, 996–1010 (2012).
   PubMed Web of Science ®Google Scholar
• Chen L , LiY, ZhaoQ, PengH, HouT. ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques. Mol. Pharm.8, 889–900 (2011).
   PubMed Web of Science ®Google Scholar
• Broccatelli F , CarosatiE, NeriAet al. A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields. J. Med. Chem.54, 1740–1751 (2011).
   PubMed Web of Science ®Google Scholar
• Shen J , ChengF, XuY, LiW, TangY. Estimation of ADME properties with substructure pattern recognition. J. Chem. Inf. Model50, 1034–1041 (2010).
   PubMed Web of Science ®Google Scholar
• Pham-The H , González‐ÁlvarezI, BermejoMet al. In Silico prediction of Caco‐2 cell permeability by a classification QSAR approach. Mol. Inf.30, 376–385 (2011).
   PubMed Web of Science ®Google Scholar
• Kido Y , MatssonP, GiacominiKM. Profiling of a prescription drug library for potential renal drug–drug interactions mediated by the organic cation transporter 2. J. Med. Chem.54, 4548–4558 (2011).
   PubMed Web of Science ®Google Scholar
• Carbon-Mangels M , HutterMC. Selecting relevant descriptors for classification by Bayesian estimates: a comparison with decision trees and support vector machines approaches for disparate datasets. Mol. Inf.30, 885–895 (2011).
   PubMed Web of Science ®Google Scholar
• Lagunin A , FilimonovD, ZakharovAet al. Computer‐aided prediction of rodent carcinogenicity by PASS and CISOC‐PSCT. QSAR Comb. Sci.28, 806–810 (2009).
   Google Scholar
• Wang J , KrudyG, HouT, ZhangW, HollandG, XuX. Development of reliable aqueous solubility models and their application in druglike analysis. J. Chem. Inf. Model.47, 1395–1404 (2007).
   PubMed Web of Science ®Google Scholar
• Murray CW , ErlansonDA, HopkinsALet al. Validity of ligand efficiency metrics. ACS Med. Chem. Lett.5, 616–618 (2014).
   PubMed Web of Science ®Google Scholar
• Varma MV , FengB, ObachRSet al. Physicochemical determinants of human renal clearance. J. Med. Chem.52, 4844–4852 (2009).
   PubMed Web of Science ®Google Scholar
• Schuster D , LaggnerC, LangerT. Antitargets: prediction and prevention of drug side effects. VazRJ, KlabundeT ( Eds). Wiley-VCH, Weinheim, Germany (2008).
   Google Scholar
• Dresser GK , SpenceJD, BaileyDG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin. Pharmacokinet.38, 41–57 (2000).
   PubMed Web of Science ®Google Scholar
• Doherty KR , WappelRL, TalbertDRet al. Multiparameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes. Toxicol. Appl. Pharmacol.272, 245–255 (2013).
   PubMed Web of Science ®Google Scholar
• Hansen K , MikaS, SchroeterTet al. Benchmark data set for in silico prediction of Ames mutagenicity. J. Chem. Inf. Model.49, 2077–2081 (2009).
   PubMed Web of Science ®Google Scholar
• Zhu H , MartinTM, YeL, SedykhA, YoungDM, TropshaA. Quantitative structure-activity relationship modeling of rat acute toxicity by oral exposure. Chem. Res. Toxicol.22, 1913–1921 (2009).
   PubMed Web of Science ®Google Scholar
• Leeson PD , SpringthorpeB. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat. Rev. Drug Discov.6, 881–890 (2007).
   PubMed Web of Science ®Google Scholar
• OECD 471, 1997. Organisation for economic co-operation and development (OECD), OECD guidelines for testing of chemicals; guideline no. 471: genetic toxicology: bacterial reverse mutation test ( adopted 21 July 1997). https://www.oecd-ilibrary.org/environment/test-no-471-bacterial-reverse-mutation-test_9789264071247-en
   Google Scholar
• OECD 423, 2001. Organisation for economic co-operation and development (OECD), OECD guidelines for the testing of chemicals, guideline no. 423: acute oral toxicity – acute toxic class method ( adopted 17 December 2001). https://www.oecd-ilibrary.org/environment/test-no-423-acute-oral-toxicity-acute-toxic-class-method_9789264071001-en
   Google Scholar
• Irwin S . Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacology13, 222–257 (1968).
   PubMed Web of Science ®Google Scholar
• Oh KT , BronichTK, KabanovAV. Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic® block copolymers. J. Control. Rel.94, 411–422 (2004).
   PubMed Web of Science ®Google Scholar
• Wei Z , HaoJ, YuanSet al. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int. J. Pharm.376, 176–185 (2009).
   PubMed Web of Science ®Google Scholar
• Bruce L , BruceI. Polymer-based anticancer agents. WO 2007/123468 A1 (2007).
   Google Scholar
• Hu J , HanY, WangJet al. Discovery of selective EGFR modulator to inhibit L858R/T790M double mutants bearing a N-9-diphenyl-9H-purin-2-amine scaffold. Bioorg. Med. Chem.26, 1810–1822 (2018).
   PubMed Web of Science ®Google Scholar
• Guan Y , HuangJ, ZuoLet al. Effect of pluronic P123 and F127 block copolymer on P-glycoprotein transport and CYP3 A metabolism. Arch. Pharmacol. Res.34, 1719–1728 (2011).
   PubMed Web of Science ®Google Scholar
• Patra A , SatpathyS, ShenoyAK, BushJA, KaziM, HussainMD. Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers. Int. J. Nanomed.13, 2869–2881 (2018).
   PubMed Web of Science ®Google Scholar